• Net revenue increased by 10 per cent to EUR 87.6m (79.9) with organic growth of 10 per cent
• Adjusted EBITA increased 20 per cent to EUR 21.9m (18.3) corresponding to a margin of 25.0 per cent (22.9)
• Operating profit (EBIT) increased 2 per cent to EUR 10.1m (9.9)
• Profit of EUR -1.9m (7.6), negatively impacted by EUR 5.0m non-realised currency impact recognised in the financial items, and earnings per share before and after dilution EUR -0.00 (0.02)
• Cash flow from operating activities of EUR 16.7m (11.6)

“We delivered another quarter with double-digit organic growth and margin expansion. Adjusted EBITA grew with 20 per cent to EUR 21.9 million, and we strengthened our cash flow from operations as we further improved our processes for inventory management. The acquisition of the global veterinary dental company iM3, completed in October, marked our entrance into a new fast-growing niche and represents a key strategic milestone for Vimian”, says Patrik Eriksson, CEO of Vimian Group.

A telephone and webcast will be held for investors, analysts, and media, today at 09.00 (CET). The conference will be held in English and include a question-and-answer session.

To attend the telephone conference:
Dial-in number to the teleconference will be received by registering on the link below. After the registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.
https://conference.financialhearings.com/teleconference/?id=50047234

To attend the webcast:
Link: https://ir.financialhearings.com/vimian-group-q3-report-2024

Related presentation materials will be available on Vimian’s website (https://vimian.com/investors/reports-and-presentations/) ahead of the telephone and web conference.